2/11/2021 4:09:53 PM
CryoLife Q4 Non-GAAP EPS $0.20 Vs $0.11 Prior Year
11/4/2020 4:16:02 PM
CryoLife Q3 Loss/share $0.08 Vs. Breakeven Year Ago
9/2/2020 4:02:47 PM
CryoLife Acquires Ascyrus Medical
7/30/2020 4:38:19 PM
CryoLife Q2 Loss/share $0.10 Vs. Profit $0.07 Year Ago
6/19/2020 7:07:34 AM
CryoLife Announces Pricing Of $100 Mln Offering Of 4.250% Convertible Senior Notes Due 2025
6/18/2020 7:07:55 AM
CryoLife Intends To Offer $100 Mln Of Convertible Senior Notes Due 2025
4/30/2020 4:32:17 PM
CryoLife Q1 Loss/share $0.18 Vs. Loss $0.01 Year Ago
2/13/2020 4:11:33 PM
CryoLife Q4 Loss/share $0.02, Same As Last Year
12/23/2019 8:31:46 AM
CryoLife Gets FDA Authorization To Commence PROACT Xa Clinical Trial
12/19/2019 8:33:49 AM
Misonix To Have Exclusive US Commercialization Rights For CryoLife's NeoPatch Product
12/2/2019 8:09:56 AM
CryoLife Secures CE Mark For E-nside Thoraco-abdominal Stent Graft
12/2/2019 8:09:18 AM
CryoLife Secures CE Mark For E-nya Thoracic Stent Graft
9/11/2019 4:04:03 PM
CryoLife Enters Into Distribution Agreement With Endospan
7/30/2019 4:21:40 PM
CryoLife Q2 EPS $0.07 Vs. $0.01 Year Ago